Astex Pharmaceuticals Company Profile (NASDAQ:SUPG)

About Astex Pharmaceuticals (NASDAQ:SUPG)

Astex Pharmaceuticals logoAstex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SUPG
  • CUSIP: N/A
  • Web: N/A
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
  • Dividend Yield: 1.0%
Frequently Asked Questions for Astex Pharmaceuticals (NASDAQ:SUPG)

What is Astex Pharmaceuticals' stock symbol?

Astex Pharmaceuticals trades on the NASDAQ under the ticker symbol "SUPG."

Who are some of Astex Pharmaceuticals' key competitors?

How do I buy Astex Pharmaceuticals stock?

Shares of Astex Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Astex Pharmaceuticals' stock price today?

One share of Astex Pharmaceuticals stock can currently be purchased for approximately $2.03.

MarketBeat Community Rating for Astex Pharmaceuticals (NASDAQ SUPG)
Community Ranking:  3.8 out of 5 (  )
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Astex Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Astex Pharmaceuticals (NASDAQ:SUPG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Astex Pharmaceuticals (NASDAQ:SUPG)
No equities research coverage for this company has been tracked by


Earnings History for Astex Pharmaceuticals (NASDAQ:SUPG)
No earnings announcements for this company have been tracked by


Earnings Estimates for Astex Pharmaceuticals (NASDAQ:SUPG)
Current Year EPS Consensus Estimate: $0.17 EPS


Dividend History for Astex Pharmaceuticals (NASDAQ:SUPG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Astex Pharmaceuticals (NASDAQ:SUPG)
No insider trades for this company have been tracked by


Headline Trends for Astex Pharmaceuticals (NASDAQ:SUPG)
Latest Headlines for Astex Pharmaceuticals (NASDAQ:SUPG)
DateHeadline logoAstex to Showcase Its Next-Generation... - November 29 at 3:38 PM logoBladder Cancer Pipeline Market Global Analysis and Therapeutics Development for H2 2016 - November 15 at 11:31 AM



Astex Pharmaceuticals (SUPG) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff